Statement Of Cash Flows [Abstract]

ERYTECH Pharma S.A. - Filing #858938

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
23 663 EUR
49 615 EUR
62 522 EUR
Increase (decrease) in working capital
8 098 EUR
7 153 EUR
10 802 EUR
Adjustments for decrease (increase) in trade and other receivables
63,000 EUR
8,000 EUR
33,000 EUR
Adjustments for increase (decrease) in trade and other payables
9 220 EUR
6 477 EUR
6 913 EUR
Adjustments for decrease (increase) in other current assets
2 734 EUR
94,000 EUR
2 829 EUR
Adjustments for increase (decrease) in other current liabilities
1 548 EUR
574,000 EUR
669,000 EUR
Adjustments for gains (losses) on change in fair value of derivatives
EUR
1 175 EUR
652,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
5,000 EUR
192,000 EUR
421,000 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
586,000 EUR
145,000 EUR
4,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.